Novartis announces FDA filing acceptance and Priority Review of brolucizumab (RTH258) for patients with wet AMD Read more
Alnylam initiates ILLUMINATE-B phase 3 pediatric study of Lumasiran to treat primary hyperoxaluria type 1 Read more
Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development Agreement to Develop iPSC-based Diabetes Treatment Read more
Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis Read more
Enesi Pharma and BARDA Drive Enter Public-Private Partnership to Develop ImplaVax Solid Dose Vaccine Delivery Technology Against Influenza Read more
Pulmatrix and Cipla enter into Definitive Agreement for the Development and Commercialization of Pulmazole Read more